Filing Details

Accession Number:
0001731122-21-001127
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-01 21:48:40
Reporting Period:
2021-06-29
Accepted Time:
2021-07-01 21:48:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314052 Anavex Life Sciences Corp. AVXL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1196573 U Christopher Missling 51 W 52Nd Street, 7Th Floor
New York NY 10019
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-29 51,620 $1.32 1,069,830 No 4 M Direct
Common Stock Disposition 2021-06-29 51,620 $26.00 1,018,210 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-06-29 51,620 $0.00 51,620 $1.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
73,380 2024-05-08 No 4 M Direct
Footnotes
  1. The options subject to this grant vested over 4 years on May 8, 2015, May 8, 2016, May 8, 2017, May 8, 2018.